Brenig Therapeutics initiates first-in-human study of BT-409, a brain-selective NLRP3 inhibitor: Boston, Massachusetts Monday, January 19, 2026, 18:00 Hrs [IST] Brenig Therapeutic ...
The New England Patriots meet the Houston Texans in the AFC divisional round today. Follow along as we provide live coverage, ...
It was a sloppy, snowy matchup in Foxborough, but the Patriots did enough to hold the ferocious Houston defense at bay.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback